http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2450812-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d9cbedb4ca1602abbe920ebc9dbdb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40d4b0e1768a2ad4f506927b5ab53370 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 |
| filingDate | 2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeae138f66bb7aeba14d68ece172786a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda51371596e3cddc5cb9601c134546b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9f6292a933bbc5084c87dd057d5046a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5bedfd4c6be439eeebee3dc6554be0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8a54a9bac9f5e25f38a0a21ff9579f9 |
| publicationDate | 2012-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2450812-C1 |
| titleOfInvention | Drug for respiratory infectious diseases glucaferon® |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: drug for respiratory diseasescontains a basidiomycetes extract, herbal proteolytic enzyme Bromeline, succinic acid, rutin and calcium stearate in the following ratio (wt %): proteolytic enzyme Bromeline - 3-10; edible basidiomycetes extract - 20-25; rutin (vitamin) - 20-25; succinic acid - 40-50; calcium stearate - the rest. As the basidiomycetes extract, it contains hiratake extract, shiitake mushroom extract or reishi extract. The drug Glucaferon® has an integrated effect on a body, allows essentially increasing anti-infective properties. It can be used both independently, and with underlying conventional therapy with using antiviral preparations or antibiotics. n EFFECT: invention refers to medicine, namely to pathogenetic preparations for infectious respiratory diseases produced of natural herbal raw material. n 4 cl, 5 tbl, 5 ex, 6 dwg |
| priorityDate | 2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.